Nektar Therapeutics (NKTR): Pfizer continues to be serious about Exubera
Go back to Nektar Therapeutics (NKTR): Pfizer continues to be serious about Exubera| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 75.56 +1.03 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.53 | 52 Week High | $19.98 | |||
| Open | $75.05 | 52 Week Low | $10.52 | |||
| Day High | $76.23 | P/E | N/A | |||
| Day Low | $74.98 | EPS | $-1.45 | |||
| Volume | 42,202 | |||||
